Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
N
Nabeshima, Akira
Kyushu University Department of Orthopaedic Surgery
(
P 125
)
EFFECTIVENESS OF PERIPHERAL BLOOD IMMUNE-RELATED MARKERS IN SELECTING NOVEL THERAPEUTIC AGENTS FOR ADVANCED SOFT TISSUE SARCOMA
Akira Nabeshima
Favorite
Nacev, Benjamin
Memorial Sloan Kettering Cancer Center
(
P 134
)
PHASE II STUDY OF RUCAPARIB AND NIVOLUMAB IN PATIENTS WITH LEIOMYOSARCOMA
Benjamin Nacev
Favorite
Nadel, Helen
Stanford Children's Health
(
P 023
)
FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS TREATED WITH SURGERY ON AEWS1031: A REPORT FROM THE CHILDRENS ONCOLOGY GROUP
Helen Nadel
Favorite
Nagarajan, Raj
Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center
(
P 118
)
SOMATOSTATIN RECEPTOR TYPE 2 EXPRESSION IN SARCOMA
Raj Nagarajan
Favorite
Nagasawa, Hiroyuki
Akita University Graduate School of Medicine
(
P 084
)
PROGNOSTIC FACTORS IN PATIENTS WITH DISTANT SOFT TISSUE METASTASIS OF CARCINOMA
Hiroyuki Nagasawa
Favorite
(
P 285
)
IMPACT OF ACRIDINE ORANGE IN PATIENTS WITH LOCAL RECURRENT SOFT TISSUE SARCOMA
Hiroyuki Nagasawa
Favorite
Nakagawa, Makoto
Duke University
(
P 125
)
EFFECTIVENESS OF PERIPHERAL BLOOD IMMUNE-RELATED MARKERS IN SELECTING NOVEL THERAPEUTIC AGENTS FOR ADVANCED SOFT TISSUE SARCOMA
Makoto Nakagawa
Favorite
Nakashima, Yasuharu
Kyushu University Department of Orthopaedic Surgery
(
P 125
)
EFFECTIVENESS OF PERIPHERAL BLOOD IMMUNE-RELATED MARKERS IN SELECTING NOVEL THERAPEUTIC AGENTS FOR ADVANCED SOFT TISSUE SARCOMA
Yasuharu Nakashima
Favorite
Nalla, Suhas
University of Texas at Dallas
(
P 248
)
RESULTS OF A NEOADJUVANT REGIMEN USING A FIXED DOSE OF ADRIAMYCIN AS AN ELECTRON AFFINIC AGENT WITH 27GY FOLLOWED BY WIDE LOCAL RESECTION OF SOFT TISSUE SARCOMAS
Suhas Nalla
Favorite
Namløs, Heidi
Oslo University Hospital
(
P 114
)
PROGNOSTIC IMPACT OF CIRCULATING TUMOR DNA DETECTION IN FIRST-LINE TREATMENT OF ADVANCED GASTROINTESTINAL STROMAL TUMOR
Heidi Namløs
Favorite
Nandkumar, Preeya
Zentalis
(
P 144
)
A PHASE 1/2 DOSE ESCALATION/EXPANSION STUDY OF ZN-C3 PLUS GEMCITABINE IN RELAPSED/REFRACTORY OSTEOSARCOMA
Preeya Nandkumar
Favorite
Naous, Rana
University of Pittsburgh Medical Center
(
P 087
)
RATING THE EFFICACY OF DIAGNOSTIC IMAGING STUDIES PERFORMED FOR THE WORK-UP OF MUSCULOSKELETAL MASSES
Rana Naous
Favorite
Napolitano, Andrea
The Royal Marsden NHS Foundation Trust
(
P 152
)
FINAL RESULTS OF GEMMK: A PHASE I TRIAL OF GEMCITABINE AND PEMBROLIZUMAB IN PATIENTS WITH LEIOMYOSARCOMA AND UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Andrea Napolitano
Favorite
Napolitano, Andrea
Royal Marsden Hospital NHS Trust
(
P 185
)
PHARMACOLOGICAL INHIBITION OF GLYOXALASE-1 AS NOVEL THERAPEUTIC STRATEGY TO POTENTIATE TRABECTEDIN ANTI-TUMOR EFFECT IN SOFT TISSUE SARCOMA PRECLINICAL MODELS
Andrea Napolitano
Favorite
Narasimhan, Supraja
Deciphera Pharmaceuticals, LLC
(
P 116
)
SAFETY AND EFFICACY OF VIMSELTINIB IN TENOSYNOVIAL GIANT CELL TUMOUR: LONG-TERM PHASE 1 UPDATE
Supraja Narasimhan
Favorite
Nassif, Elise
The University of Texas MD Anderson Cancer Center
(
P 048
)
IMMUNE INFILTRATION AS PROGNOSTIC FACTORS IN METASTATIC LEIOMYOSARCOMA
Elise Nassif
Favorite
Nathenson, Michael
Study Physician, GSK
(
P 189
)
PROGNOSTIC IMPACT OF NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA-1 EXPRESSION AND HUMAN LEUKOCYTE ANTIGEN SUBTYPES IN METASTATIC SYNOVIAL SARCOMA
Michael Nathenson
Favorite
Nathrath, Michaela
Klinikum Kassel
(
P 014
)
A PLETHORA OF DISEASE-ASSOCIATED ALTERATIONS IN OSTEOSARCOMA
Michaela Nathrath
Favorite
(
P 024
)
GENETIC REARRANGEMENTS IN 12Q-AMPLIFIED OSTEOSARCOMA RESULT IN ECTOPIC GENE EXPRESSION THROUGH TRANSPOSITION OF REGULATORY ELEMENTS AND SELECTIVE AMPLIFICATION
Michaela Nathrath
Favorite
Navarria, Pierina
Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089, Italy.
(
P 02
)
CLINICAL CHARACTERISTICS AND OUTCOME OF ADOLESCENT AND YOUNG ADULTS SOFT TISSUE AND BONE SARCOMAS AT AN ADULT CANCER CENTER: THE BENEFITS OF A DEDICATED, MULTIDISCIPLINARY MANAGEMENT
Pierina Navarria
Favorite
Navarria, Pierina
Humanitas Research Hospital
(
P 057
)
SARCOMA MICROENVIRONMENT CHARACTERIZATION: CLINICOPATHOLOGICAL ANALYSIS OF ONE-HUNDRED TWENTY-SIX CASES
Pierina Navarria
Favorite
(
P 224
)
THE ROLE OF NEOADJUVANT CHEMOTHERAPY IN RETROPERITONEAL SARCOMA. A CASE-MATCHED ANALYSIS.
Pierina Navarria
Favorite
Navarro, Jose Luis
HCU VIRGEN ARRIXACA
(
P 318
)
NEOADJUVANT CHEMORADIOTHERAPY IN ADVANCED SOFT TISSUE SARCOMA. UPDATED NASAR STUDY
Jose Luis Navarro
Favorite
Navarro, Willis
Aadi Bioscience
(
P 156
)
MANAGEMENT OF ADVERSE EVENTS IN THE AMPECT TRIAL OF NAB-SIROLIMUS FOR THE TREATMENT OF ADVANCED MALIGNANT PECOMA
Willis Navarro
Favorite
(
P 167
)
STUDY-END ANALYSIS FROM AMPECT, AN OPEN-LABEL, PHASE 2 REGISTRATION TRIAL OF PATIENTS WITH ADVANCED MALIGNANT PECOMA TREATED WITH nab-SIROLIMUS, SHOWING DURABILITY OF RESPONSE AND LONG-TERM SAFETY
Willis Navarro
Favorite
(
P 313
)
A PHASE 2, MULTICENTER, OPEN-LABEL BASKET TRIAL OF NAB-SIROLIMUS FOR PATIENTS WITH MALIGNANT SOLID TUMORS HARBORING PATHOGENIC INACTIVATING ALTERATIONS IN TSC1 OR TSC2 GENES (PRECISION I)
Willis Navarro
Favorite
Navenot, Jean-Marc
Adaptimmune
(
P 127
)
IDENTIFYING MAGE-A4-POSITIVE TUMORS FOR SPEAR T-CELL THERAPIES IN HLA-A*02-ELIGIBLE PATIENTS
Jean-Marc Navenot
Favorite
Navid, Fariba
Children's Hospital Los Angeles
(
P 037
)
SURVIVAL OUTCOMES AND POST-SURGICAL MORBIDITY BASED ON SURGICAL APPROACH TO PULMONARY METASTASECTOMY IN PATIENTS WITH OSTEOSARCOMA
Fariba Navid
Favorite
(
P 045
)
DETECTION OF CELL-FREE TUMOR DNA IN PATIENTS WITH NEWLY DIAGNOSED PEDIATRIC BONE AND SOFT TISSUE SARCOMAS
Fariba Navid
Favorite
(
P 151
)
CLINICAL PRESENTATION OF OSTEOSARCOMA PATIENTS WITH ACUTE METHOTREXATE TOXICITY TREATED WITH GLUCARPIDASE
Fariba Navid
Favorite
Neijenhuis, Ralph
Leiden University Medical center
(
P 051
)
NON-INVASIVE DETECTION OF SOFT TISSUE SARCOMA USING VOLATILE ORGANIC COMPOUNDS IN EXHALED BREATH: A PILOT STUDY
Ralph Neijenhuis
Favorite
Nelson, Scott
University of California, Los Angeles
(
P 183
)
OSTEOSARCOMA ORGANOIDS RECAPITULATE TUMOR CHARACTERISTICS AND MAINTAIN HETEROGENEITY
Scott Nelson
Favorite
(
P 184
)
PAN-SARCOMA ORGANOID SCREENING PIPELINE
Scott Nelson
Favorite
(
P 243
)
MUTATIONAL ANALYSIS OF PRIMARY AND ADVANCED CHORDOMA TISSUE USING NEXT-GENERATION SEQUENCING
Scott Nelson
Favorite
Nemat-Gorgani, Neda
Stanford University
(
P 130
)
MONITORING SOFT TISSUE SARCOMA RESPONSE TO IMMUNE CHECKPOINT INHIBITION AND CRYOTHERAPY WITH CIRCULATING TUMOR DNA ANALYSIS
Neda Nemat-Gorgani
Favorite
Nessim, Carolyn
University of Ottawa
(
P 112
)
PREVALENCE AND PROGNOSTIC VALUE OF TARGETABLE RECEPTORS IN EXTRA-UTERINE LEIOMYOSARCOMA
Carolyn Nessim
Favorite
(
P 218
)
PRIMARY PELVIC SOFT TISSUE SARCOMAS (PELVISARC): OUTCOMES IN A SERIES OF 401 PATIENTS FROM THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Carolyn Nessim
Favorite
(
P 220
)
PROMOTING GLOBAL EDUCATION IN THE FIELD OF RETROPERITONEAL SARCOMA: THE FIRST OPEN-ACCESS EDUCATIONAL WEBINAR SERIES BY THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP
Carolyn Nessim
Favorite
Nevière, Zoé
Oncogenetic, Department of Biopathology, Comprehensive Cancer Center François Baclesse
(
P 189
)
PROGNOSTIC IMPACT OF NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA-1 EXPRESSION AND HUMAN LEUKOCYTE ANTIGEN SUBTYPES IN METASTATIC SYNOVIAL SARCOMA
Zoé Nevière
Favorite
Neville, Kathleen
C4 Therapeutics
(
P 312
)
A PHASE 1/2 STUDY OF CFT8634, A NOVEL BIFUNCTIONAL DEGRADATION ACTIVATING COMPOUND (BIDAC) DEGRADER OF BRD9, IN SYNOVIAL SARCOMA AND SMARCB1-NULL TUMORS
Kathleen Neville
Favorite
Ng, Cedric
National Cancer Centre Singapore
(
P 174
)
ESTABLISHMENT AND CHARACTERIZATION OF A PATIENT-DERIVED SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA CELL LINE MODEL
Cedric Ng
Favorite
NGO, CARINE
INSTITUT GUSTAVE ROUSSY
(
P 060
)
TOWARD A NEW GENOMIC AND CLINICO-PATHOLOGIC CLASSIFICATION OF UTERINE ADENOSARCOMAS
CARINE NGO
Favorite
(
P 217
)
PLANNED MARGINAL (R1) RESECTION IN PRIMARY RETROPERITONEAL SARCOMAS: RETROSPECTIVE SERIES ON 168 PATIENTS FROM A NATIONAL SPECIALIZED REFERRAL CENTER
CARINE NGO
Favorite
Ng, Tony
Department of Pathology, University of British Columbia
(
P 050
)
MULTIPLEX DETECTION OF TRANSLOCATION ASSOCIATED SARCOMAS WITH COMBINED FUSION JUNCTION SPANNING PROBES AND EXON IMBALANCE ANALYSIS
Tony Ng
Favorite
Nguyen, Huyen Thi Lam
University of California, Los Angeles
(
P 183
)
OSTEOSARCOMA ORGANOIDS RECAPITULATE TUMOR CHARACTERISTICS AND MAINTAIN HETEROGENEITY
Huyen Thi Lam Nguyen
Favorite
(
P 184
)
PAN-SARCOMA ORGANOID SCREENING PIPELINE
Huyen Thi Lam Nguyen
Favorite
Nicolas, Nayla
Institut Curie
(
P 270
)
ORAL VINORELBINE ACTIVITY FOR PROGRESSIVE DESMOID FIBROMATOSIS TUMOURS IN YOUNG PATIENTS
Nayla Nicolas
Favorite
Nielsen, Torsten
Department of Pathology, VGH
(
P 050
)
MULTIPLEX DETECTION OF TRANSLOCATION ASSOCIATED SARCOMAS WITH COMBINED FUSION JUNCTION SPANNING PROBES AND EXON IMBALANCE ANALYSIS
Torsten Nielsen
Favorite
(
P 129
)
MATURE DENDRITIC CELLS ON TISSUE MICROARRAY CORES CORRELATE WITH THE PRESENCE OF ADJACENT TERTIARY LYMPHOID STRUCTURES IN EPITHELIOID SARCOMA
Torsten Nielsen
Favorite
Niessen, Wiro
Erasmus Medical Center Rotterdam and Delft University of Technology
(
P 044
)
AUTOMATIC SEGMENTATION USING DEEP LEARNING TO DISTINGUISH BETWEEN 9 TYPES OF SOFT-TISSUE TUMORS WITH RADIOMICS
Wiro Niessen
Favorite
Niggli, Cedric
Swiss Sarcoma Network
(
P 072
)
ESTABLISHING A SARCOMA REFERENCE SCORE FOR EQ-5D
Cedric Niggli
Favorite
Nilsson, Björn
Lund University
(
P 014
)
A PLETHORA OF DISEASE-ASSOCIATED ALTERATIONS IN OSTEOSARCOMA
Björn Nilsson
Favorite
Nilsson, Jenny
Lund University
(
P 014
)
A PLETHORA OF DISEASE-ASSOCIATED ALTERATIONS IN OSTEOSARCOMA
Jenny Nilsson
Favorite
(
P 024
)
GENETIC REARRANGEMENTS IN 12Q-AMPLIFIED OSTEOSARCOMA RESULT IN ECTOPIC GENE EXPRESSION THROUGH TRANSPOSITION OF REGULATORY ELEMENTS AND SELECTIVE AMPLIFICATION
Jenny Nilsson
Favorite
(
P 242
)
LIPOSARCOMAS WITH 12Q AMPLIFICATION - CAN GENETIC CHANGES DISCLOSE THE DEVELOPMENT AND ORIGIN OF RING CHROMOSOMES?
Jenny Nilsson
Favorite
Nishida, Yoshihiro
Nagoya University Hospital
(
P 262
)
CLINICAL RESULTS OF ACTIVE SURVEILLANCE FOR EXTRA ABDOMINAL DESMOID TYPE FIBROMATOSIS
Yoshihiro Nishida
Favorite
(
P 322
)
PHASE 2 SINGLE-ARM CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AURANOFIN IN ADULT PATIENTS WITH PROGRESSIVE DESMOID
Yoshihiro Nishida
Favorite
Nishikawa, Tadaaki
Department of Medical Oncology, National Cancer Center Hospital
(
P 147
)
ANALYSIS OF INFLAMMATORY BIOMARKERS AS PREDICTORS OF TREATMENT EFFICACY IN SOFT TISSUE SARCOMA TREATED WITH TRABECTEDIN
Tadaaki Nishikawa
Favorite
Nishisho, Toshihiko
Department of Orthopedics Institute of Biomedical Sciences
(
P 275
)
ASSESSMENT OF SURGICAL MARGIN CLASSIFICATION FOR SOFT TISSUE SARCOMA: DEFINITIONS OF ADEQUATE MARGINS SYSTEM FOR PLANNING AND EVALUATION
Toshihiko Nishisho
Favorite
Niu, Xiaohui
Department of Orthopaedic Oncology Surgery, Beijing Ji Shui Tan Hospital, Peking University
(
P 164
)
PRELIMINARY PHASE 1B RESULTS OF ABSK021 FOR ADVANCED TENOSYNOVIAL GIANT CELL TUMOR: SIGNIFICANT ANTITUMOR ACTIVITY AND FAVOURABLE SAFETY PROFILE
Xiaohui Niu
Favorite
Nixon, Ioanna
Beatson West of Scotland Cancer Centre
(
P 073
)
EVALUATING DISTRESS AND THE PATIENT EXPERIENCE OF SARCOMA PATIENTS IN THE WEST OF SCOTLAND
Ioanna Nixon
Favorite
Noguchi, Emi
Department of Medical Oncology, National Cancer Center Hospital
(
P 147
)
ANALYSIS OF INFLAMMATORY BIOMARKERS AS PREDICTORS OF TREATMENT EFFICACY IN SOFT TISSUE SARCOMA TREATED WITH TRABECTEDIN
Emi Noguchi
Favorite
Nomikos, Julia
Lunenfeld-Tanenbaum Research Institute - Mount Sinai Hospital
(
P 124
)
EFFECT OF MAGNETIC RESONANCE GUIDED HIGH INTENSITY FOCUSED ULTRASOUND AND CHEMOTHERAPY ON THE IMMUNE PROFILE OF A MURINE MODEL OF RHABDOMYOSARCOMA
Julia Nomikos
Favorite
Norenberg, Ricarda
Chrestos Concept GmbH & Co. KG
(
P 107
)
LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT PATIENTS WITH TRK FUSION SARCOMAS
Ricarda Norenberg
Favorite
Noronha, Vanita
Tata Memorial Centre
(
P 03
)
DEMOGRAPHICS, PRACTICE PATTERNS, CHALLENGES AND OUTCOMES OF SYNOVIAL SARCOMA PATIENTS FROM A TERTIARY CARE CENTRE FROM A LARGE LOW-MIDDLE INCOME COUNTRY
Vanita Noronha
Favorite
(
P 09
)
OUTCOMES, PROGNOSTIC FACTORS AND TREATMENT COMPLIANCE IN OSTEOSARCOMA CASES TREATED WITH AN INDIGENOUS, LOW-COST PROTOCOL, OGS-12, IN A TERTIARY CARE CANCER CENTRE IN INDIA
Vanita Noronha
Favorite
Norris, Grayson
University Of Oklahoma College of Medicine
(
P 236
)
EVALUATION OF HISTOLOGIC CHANGES OF TENOSYNOVIAL GIANT CELL TUMORS FOLLOWING TREATMENT WITH PEXIDARTINIB
Grayson Norris
Favorite
(
P 248
)
RESULTS OF A NEOADJUVANT REGIMEN USING A FIXED DOSE OF ADRIAMYCIN AS AN ELECTRON AFFINIC AGENT WITH 27GY FOLLOWED BY WIDE LOCAL RESECTION OF SOFT TISSUE SARCOMAS
Grayson Norris
Favorite
(
P 297
)
PREOPERATIVE EMBOLIZATION TO REDUCE THE RISK OF HEMORRHAGE FOR HEMANGIOPERICYTOMA RESECTION
Grayson Norris
Favorite
Noujaim, Jonathan
Maisonneuve-Rosemont Hospital
(
P 049
)
IMPLEMENTATION OF A ROUTINE DIAGNOSTIC NEXT GENERATION SEQUENCING PANEL OF FUSION-POSITIVE SARCOMAS: A SINGLE CENTER EXPERIENCE
Jonathan Noujaim
Favorite
(
P 165
)
REAL- WORLD EXPERIENCE OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH RECURRENT BONE TUMOURS (BT): A CANSARCC STUDY
Jonathan Noujaim
Favorite
Novak, Marko
Department of Surgical Oncology, Institute of Oncology Ljubliana
(
P 218
)
PRIMARY PELVIC SOFT TISSUE SARCOMAS (PELVISARC): OUTCOMES IN A SERIES OF 401 PATIENTS FROM THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Marko Novak
Favorite
Novak, Rostislav
University of Toronto
(
P 284
)
HOW DO THE OUTCOMES OF RADIATION ASSOCIATED PELVIC AND SACRAL BONE SARCOMAS COMPARE TO PRIMARY OSTEOSARCOMAS FOLLOWING SURGICAL RESECTION?
Rostislav Novak
Favorite
Nysom, Karsten
University Hospital Rigshospitalet
(
P 148
)
ANALYSIS OF REECUR TRIAL DATA TO EVALUATE POTENTIAL PROGNOSTIC FACTORS IN RECURRENT AND PRIMARY REFRACTORY EWING SARCOMA (RR-ES)
Karsten Nysom
Favorite
Nystrom, Luke
Cleveland Clinic
(
P 311
)
VIRTUAL VISITS FOR SARCOMAS AND OTHER RARE CANCERS INCLUDING DESMOIDS: THE EVOLUTION OF INFORMATION AND EDUCATIONAL OPPORTUNITIES TO IMPOVE HEALTH: 2017-2022
Luke Nystrom
Favorite
Back to Top
